Dose Proportionality of TFV-DP in Mucosal Tissue, and Endogenous Nucleotide Quantification, After a Single Dose of GS-7430 in Women
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B; HIV-1 infections
- Focus Pharmacokinetics
- 24 Mar 2017 Results published in the Journal of Antimicrobial Chemotherapy
- 29 Nov 2016 Status changed from active, no longer recruiting to completed.
- 04 Nov 2015 Status changed from recruiting to active, no longer recruiting as per the protocol amendment reported by ClinicalTrials.gov.